{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:37:31Z","timestamp":1784860651605,"version":"3.55.0"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The rapid growth of the number of advanced Parkinson\u2019s disease (PD) patients has caused a significant increase in the use of device-aided therapies (DATs), including levodopa\u2013carbidopa intestinal gel (LCIG) and continuous subcutaneous apomorphine infusion (CSAI). The objective of this study was to evaluate patients\u2019 satisfaction and the factors influencing preferences for CSAI and LCIG. Materials and Methods: The research focused on individuals diagnosed with advanced PD undergoing DAT at the Neurology Department of the University Hospital in Katowice. A telephone survey conducted between June and July 2024 evaluated the experiences of patients with LCIG and CSAI. The Parkinson\u2019s Disease Questionnaire (PDQ-8) and the Stress Scale for Family Caregivers (BSFC-s) were applied. Based on medical record data comprising reasons for the exclusion of individuals, disease-related and treatment data were collected. Results: Among the original cohort of 64 patients, 50 completed the survey, including 31 who might choose between infusion therapies. The average patient ages were 70.6 \u00b1 4.7 (CSAI) and 71.2 \u00b1 7.2 years (LCIG), with disease durations of 15 (IQR: 12\u201319) and 18 (IQR: 13\u201319) years, respectively. LCIG patients presented higher PDQ-8 scores (20 (IQR: 13\u201327) vs. 13 (IQR: 6\u201319), p = 0.008), and higher BSFC-s scores (19 (IQR: 12\u201321) vs. 9 (IQR: 2.5\u201313), p = 0.011). Furthermore, significant factors influencing patient preferences included fear of surgery (75% vs. 36.8%, p = 0.043) and concerns about DAT safety (83.3% vs. 47.4%, p = 0.049). Conclusions: LCIG and CSAI therapies offer benefits and disadvantages, with safety concerns and fear of surgery seeming to be decisive in the decision-making process.<\/jats:p>","DOI":"10.3390\/medicina61010027","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T10:17:40Z","timestamp":1735640260000},"page":"27","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Satisfaction and Preferences for Infusion Therapies in Advanced Parkinson\u2019s Disease\u2014Patient Perspective"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7458-2856","authenticated-orcid":false,"given":"Julia","family":"W\u0119grzynek-Gallina","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-7731","authenticated-orcid":false,"given":"Tomasz","family":"Chmiela","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8777-0997","authenticated-orcid":false,"given":"Micha\u0142","family":"Boro\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Health Sciences, Medical University of Silesia in Katowice, 45\/47 Ziolowa St., 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Buczek","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Hudzi\u0144ska","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Bigajski","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Waksmundzki","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Gawryluk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-660X","authenticated-orcid":false,"given":"Joanna","family":"Siuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"ref_1","first-page":"100054","article-title":"Risk factors for falls in Parkinson\u2019s disease and other parkinsonisms","volume":"1","author":"Buczek","year":"2024","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_3","first-page":"e13275","article-title":"Spectrum of Non-Motor Symptoms in Parkinson\u2019s Disease","volume":"13","author":"Kumaresan","year":"2021","journal-title":"Cureus"},{"key":"ref_4","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol., 23, 344\u2013381."},{"key":"ref_5","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators (2018). Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol., 17, 939\u2013953."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.parkreldis.2020.10.042","article-title":"Parkinson\u2019s disease advanced therapies\u2013A systematic review: More unanswered questions than guidance","volume":"83","author":"Marsili","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00702-019-02034-8","article-title":"Dynamics of device-based treatments for Parkinson\u2019s disease in Germany from 2010 to 2017: Application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation","volume":"126","author":"Richter","year":"2019","journal-title":"J. Neural. Transm."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Nijhuis, F.A.P., van den Heuvel, L., Bloem, B.R., Post, B., and Meinders, M.J. (2019). The Patient\u2019s Perspective on Shared Decision-Making in Advanced Parkinson\u2019s Disease: A Cross-Sectional Survey Study. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00896"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nyholm, D., and Bergquist, F. (2022). Optimizing Treatment of Parkinson\u2019s Disease. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020245"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mdc3.13962","article-title":"How to Use the New European Academy of Neurology\/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson\u2019s Disease","volume":"11","author":"Brinker","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/00207454.2020.1853723","article-title":"Patient preference of device-based treatment of Parkinson\u2019s disease","volume":"132","author":"Aydemir","year":"2022","journal-title":"Int. J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3233\/JPD-202104","article-title":"The Choice Between Advanced Therapies for Parkinson\u2019s Disease Patients: Why, What, and When?","volume":"10","author":"Dijk","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/mds.28596","article-title":"Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study","volume":"36","author":"Fasano","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pendergrass, A., Malnis, C., Graf, U., Engel, S., and Graessel, E. (2018). Screening for caregivers at risk: Extended validation of the short version of the Burden Scale for Family Caregivers (BSFC-s) with a valid classification system for caregivers caring for an older person at home. BMC Health Serv. Res., 18.","DOI":"10.1186\/s12913-018-3047-4"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jocn.2024.03.032","article-title":"Psychometric properties of the Parkinson\u2019s disease Questionnaire-39 and its short form Parkinson\u2019s disease Questionnaire-8: A systematic review and meta-analysis","volume":"123","author":"Ruotolo","year":"2024","journal-title":"J. Clin. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41531-023-00525-w","article-title":"Single centre prospective study of three device-assisted therapies for Parkinson\u2019s disease","volume":"9","author":"Ha","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40263-022-00963-9","article-title":"Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson\u2019s Disease: A Systematic Review and Bayesian Network Meta-analysis","volume":"36","author":"Antonini","year":"2022","journal-title":"CNS Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jval.2017.06.001","article-title":"Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease","volume":"20","author":"Marshall","year":"2017","journal-title":"Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","article-title":"BouNDless Study Group. Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): A phase 3, randomised, double-blind, double-dummy, multicentre trial","volume":"23","author":"Espay","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5603\/pjnns.99624","article-title":"Are 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for general neurologists for qualification to device-aided therapies in advanced Parkinson\u2019s Disease?","volume":"58","author":"Duda","year":"2024","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Carpi, M., Pierantozzi, M., Cofano, S., Fernandes, M., Cerroni, R., De Cillis, F., Mercuri, N.B., Stefani, A., and Liguori, C. (2023). Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson\u2019s Disease: An Exploratory Study. J. Pers. Med., 13.","DOI":"10.3390\/jpm13020242"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5603\/pjnns.97806","article-title":"Genetics of Parkinson\u2019s Disease: State-of-the-art and role in clinical settings","volume":"58","author":"Dulski","year":"2024","journal-title":"Neurol. Neurochir. Pol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/1\/27\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:02Z","timestamp":1760115302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/1\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["medicina61010027"],"URL":"https:\/\/doi.org\/10.3390\/medicina61010027","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]}}}